Follow Us:
Vinpocetine Exporter From India

Vinpocetine

Vinpocetine is a synthetic derivative of the vincamine alkaloid and is classified as a cerebral vasodilator and neuroprotective agent. It has been studied and used in some countries for conditions associated with cerebrovascular disorders and cognitive impairment. It is believed to work by inhibiting phosphodiesterase-1 (PDE1), improving cerebral blood flow and influencing neuronal metabolism. This may help support oxygen and glucose utilization in brain tissues. Vinpocetine is available in oral tablet form and, in some countries, as an injectable preparation. Common side effects include nausea, dizziness, headache, and gastrointestinal discomfort. It may also cause low blood pressure and changes in heart rhythm. Its clinical effectiveness is not well established for many proposed uses, and it should be taken only under appropriate medical supervision.

  • Dosage Form:
  • Dosage Strength:
  • Manufacturer:
  • CAS No.:
  • Status:

Applications of Vinpocetine

Vinpocetine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

is okay

Contraindication of Vinpocetine

Availability of Vinpocetine

Delivery of Vinpocetine

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Vinpocetine.

The is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Vinpocetine.

: Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA):
  • US Food and Drug Administration (USFDA):
  • European Medicines Agency (EMA):
  • African Medicines Agency (AMA):
  • National Medical Products Administration (NMPA):
  • Central Drugs Standard Control Organization (CDSCO):

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Vinpocetine, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Vinpocetine Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Vinpocetine

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Vinpocetine Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Vinpocetine, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Vinpocetine

The export of Vinpocetine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Vinpocetine Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Vinpocetine specifications, certificates of analysis, and other supporting documents required for Vinpocetine export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Vinpocetine export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Vinpocetine regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Vinpocetine documentation, labelling, Vinpocetine manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Vinpocetine Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Vinpocetine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.